(1) PKR level and post-translation modifications are excellent biomarkers for neurodegenerative diseases (e.g., AD, dementia, Parkinson’s disease, Huntington’s disease, and prion disease) and cancer (Figure 4, based on open source data). The gene discussed is EIF2AK2; the disease is Parkinson disease.